Related Experiment Videos
Refractory sprue
Andrea N Culliford1, Peter H R Green
1Division of Digestive and Liver Diseases, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, Suite 645, New York, NY 10032, USA. pg11@columbia.edu
Current Gastroenterology Reports
|September 10, 2003
Summary
Refractory sprue, a complication of celiac disease, is often caused by continued gluten intake. Aberrant T-cells define this condition, which has a poor prognosis but may respond to immunosuppressants.
Area of Science:
- Gastroenterology and Immunology
- T-cell mediated disorders
- Autoimmune diseases
Background:
- Celiac disease is an immune response to gluten, a protein found in wheat, barley, and rye.
- Gluten intolerance can lead to a T cell-mediated disorder, causing damage to the small intestine.
- Refractory sprue is a severe complication characterized by persistent symptoms despite a strict gluten-free diet.
Purpose of the Study:
- To define and classify patients with refractory sprue.
- To investigate the role of aberrant intraepithelial lymphocytes in refractory sprue.
- To explore potential treatment options and prognosis for refractory sprue.
Main Methods:
- Diagnosis of refractory sprue through exclusion of other conditions in poorly responsive patients.
- Identification and characterization of aberrant, clonally expanded, intraepithelial lymphocytes.
- Review of existing literature on well-characterized refractory sprue patient series.
Main Results:
- Continued gluten ingestion is the primary reason for non-response to a gluten-free diet.
- Aberrant clonal intraepithelial T-cell populations are key diagnostic markers for refractory sprue.
- Refractory sprue can occur with or without prior celiac disease diagnosis, and after initial dietary response.
Conclusions:
- Refractory sprue is a serious condition with a generally poor prognosis.
- Some patients may benefit from corticosteroids and immunosuppressive therapies.
- The presence of aberrant T-cells suggests refractory sprue may represent a cryptic intestinal T-cell lymphoma.